Химиопрофилактика рака предстательной железы: обзор клинических и доклинических данных

Химиопрофилактика рака предстательной железы: обзор клинических и доклинических данных

Автор: Беспалов В.Г., Муразов Я.Г., Панченко А.В.

Журнал: Экспериментальная и клиническая урология @ecuro

Рубрика: Онкоурология

Статья в выпуске: 4, 2011 года.

Бесплатный доступ

Рак предстательной железы, химиопрофилактика

Короткий адрес: https://sciup.org/142188279

IDR: 142188279

Список литературы Химиопрофилактика рака предстательной железы: обзор клинических и доклинических данных

  • Злокачественные новообразования в России в 2009 году (заболеваемость и смертность)/Под ред. В.И. Чиссова, В.В. Старинского, Г.В. Петровой. М.: ФГУ “МНИОИ им. П.А. Герцена” Минздравсоцразвития РФ. 2011. 260 с.
  • Аполихин О.И., Сивков А.В., Бешлиев Д.А., Солнцева Т.В., Комарова В.А., Зайцевская Е.В. Анализ урологической заболеваемости в Российской Федерации в 2002-2009 годах по данным официальной статистики//Экспериментальная и клиническая урология. 2010. № 1. С. 4-10.
  • Heinonen O.P., Albanes D., Virtamo J., Taylor PR., Huttunen J.K., Hartman A.M., Haapakoski J., Malila N., Rautalahti M., Ripatti S., Mäenpää H., Teerenhovi L., Koss L., Virolainen M., Edwards B.K. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial//J. Natl. Cancer Inst. 1998. Vol. 90. P. 440-446.
  • Clark L.C., Dalkin B., Krongrad A., Combs G. F Jr., Turnbull B.W., Slate E.H., Witherington R., Herlong J.H., Janosko E., Carpenter D., Borosso C., Falk S., Rounder J. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial//Br. J. Urol. 1998. Vol. 81. P. 730-734.
  • Thompson I.M., Klein E.A., Lippman S.M., Coltman C.A., Djavan B. Prevention of prostate cancer with finasteride: US/European perspective//Eur. Urol. 2003. Vol. 44. P. 650-655.
  • Andriole G.L., Bostwick D.G., Brawley O.W, Gomella L.G., Marberger M., Montorsi F., Pettaway CA, Tammela T.L., Teloken C., Tindall D.J., Somerville M.C., Wilson TH., Fowler I.L., Rittmaster R.S. Effect of dutasteride on the risk of prostate cancer//N. Engl. J. Med. 2010. Vol. 362. P. 1192-1202.
  • Ledesma M.C., Jung-Hynes B., Schmit T.L., Kumar R., Mukhtar H., Ahmad N. Selenium and vitamin E for prostate cancer: Post-SELECT (Selenium and Vitamin E Cancer Prevention Trial) status//Mol. Med. 2011. Vol. 17. P. 134-143.
  • Gaziano J.M., Glynn R.J., Christen W.G., Kurth T., Belanger C., MacFadyen J., Bubes V., Manson J.E., Sesso H.D., Buring J.E. Vitamins E and C in the prevention of prostate and total cancer in men. The Physicians’ Health Study II Randomized Controlled Trial//JAMA. 2009. Vol. 301. P. 5262.
  • Van Poppel H., Tombal B. Chemoprevention of prostate cancer with nutrients and supplements//Cancer Manag. Res. 2011. Vol. 3. P. 91-100.
  • Strope S.A., Andriole G.L. Update on chemoprevention for prostate cancer//Curr. Opin. Urol. 2010. Vol. 20. P. 194-197.
  • Сивков А.В., Ощепков В.Н. Фармакотерапия доброкачественной гиперплазии и рака предстательной железы. Финастерид: 20 лет клинической практики лечения больных аденомой предстательной железы//Consilium Medicum. 2006. Т.8. № 4. С. 43-47.
  • Finasteride: potential risk of male breast cancer//Drug Safety Update. 2009. Vol. 3. Issue 5. P. 3.
  • Messina M., Kucuk O., Lampe J.W An overview of the health effects of isoflavones with an emphasis on prostate cancer risk and prostate-specific antigen levels//J. AOAC Int. 2006. Vol. 89. 1121-1134.
  • Bettuzzi S., Rizzi F., Belloni L. Clinical relevance of the inhibitory effect of green tea catechins (GtCs) on prostate cancer progression in combination with molecular profiling of catechin-resis-tant tumors: an integrated view//Pol. J. Vet. Sci. 2007. Vol. 10. P. 57-60.
  • Schwarz S., Obermüller-Jevic U.C., Hellmis E., Koch W, Jacobi G., Biesalski H.K. Lycopene inhibits disease progression in patients with benign prostate hyperplasia//J. Nutr. 2008. Vol. 138. P. 49-53.
  • Bunker C.H., McDonald A.C., Evans R.W., de la Rosa N., Boumosleh J.M., Patrick A.L. A randomized trial of lycopene supplementation in Tobago men with high prostate cancer risk//Nutr. Cancer. 2007. Vol. 57. P. 130-137.
  • Mohanty NK, Saxena S, Singh UP, Goyal NK, Arora RP. Lycopene as a chemopreventive agent in the treatment of high-grade prostate intraepithelial neoplasia//Urol. Oncol. 2005. Vol. 23. P. 383385.
  • Greenberg N.M., DeMayo F., Finegold M.J., Medina D., Tilley WD., Aspinall J.O., Cunha G.R., Donjacour A.A., Matusik R.J., Rosen J.M. Prostate cancer in a transgenic mouse//Proc. Natl. Acad. Sci. USA. 1995. Vol. 92. P. 3439-3443.
  • Fizazi K., Navone N.M. Modeles précliniques de cancer de la prostate//Bull. Cancer. 2005. Vol. 92. P. 129-141.
  • Harper C.E., Patel B.B., Cook L.M., Wang J., Shirai T., Eltoum I.A., Lamartiniere C.A. Characterization of SV-40 Tag rats as a model to study prostate cancer//BMC Cancer. 2009. Vol. 9:30.
  • Lamb D.J., Zhang L. Challenges in prostate cancer research: animal models for nutritional studies of chemoprevention and disease progression//J. Nutr. 2005. Vol. 135 (12 Suppl.). P. 3009S-3015S.
  • Chiang C.F., Son E.L., Wu G.J. Oral treatment of the TRAMP mice with doxazosin suppresses prostate tumor growth and metastasis//Prostate. 2005. Vol. 64. P. 408-418.
  • Cho Y.M., Takahashi S., Asamoto M., Suzuki S., Tang M., Shirai T Suppressive effects of antiandrogens, finasteride and flutamide on development of prostatic lesions in a transgenic rat model//Prostate Cancer Prostatic Dis. 2007. Vol. 10. P. 378-383.
  • Esmat A.Y., Refaie F.M., Shaheen M.H., Said M.M. Chemoprevention of prostate carcinogenesis by DFMO and/or finasteride treatment in male Wistar rats//Tumori. 2002. Vol. 88. P. 513-521.
  • Kohno H., Suzuki R., Sugie S., Tsuda H., Tanaka T. Dietary supplementation with silymarin inhibits 3,2’-dimethyl-4-aminobiphenyl-induced prostate carcinogenesis in male F344 rats//Clin. Cancer Res. 2005. Vol. 11. P. 4962-4967.
  • Raina K., Rajamanickam S., Singh R.P, Deep G., Chittezhath M., Agarwal R. Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model//Cancer Res. 2008. Vol. 68. P 6822-6830.
  • Narayanan B.A., Narayanan N.K., Pttman B., Reddy B.S. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model//Clin. Cancer Res. 2004. Vol. 10. P. 7727-7737.
  • Wechter WJ., Leipold D.D., Murray E.D. Jr., Quiggle D., McCracken J.D., Barrios R.S., Greenberg N.M. E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse//Cancer Res. 2000. Vol. 60. P. 2203-2208.
  • Pollard M., Suckow M.A. Dietary prevention of hormone refractory prostate cancer in Lobund-Wistar rats: a review of studies in a relevant animal model//Comp. Med. 2006. Vol. 56. P 461-467.
  • McCormick D.L., Rao K.V, Steele VE., Lubet R.A., Kelloff G.J., Bosland M.C. Chemoprevention of rat prostate carcinogenesis by 9-cis-retinoic acid//Cancer Res. 1999. Vol. 59. P 521-524.
  • Ni J., Mai T., Pang S.T., Haque I., Huang K., DiMaggio M.A., Xie S., James N.S., Kasi D., Chemler S.R., Yeh S. In vitro and in vivo anticancer effects of the novel vitamin E ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer//Clin. Cancer Res. 2009. Vol. 15. P. 898-906.
  • Banach-Petrosky W, Ouyang X., Gao H., Nader K., Ji. Y., Suh N., DiPaola R.S., Abate-Shen C. Vitamin D inhibits the formation of prostatic intraepithelial neoplasia in Nkx3.1; Pten mutant mice//Clin. Cancer Res. 2006. Vol. 12. P. 5895-5901.
  • Venkateswaran V., Klotz L.H., Ramani M., Sugar L.M., Jacob L.E., Nam R.K., Fleshner N.E. A combination of micronutrients is beneficial in reducing the incidence of prostate cancer and increasing survival in the Lady transgenic model//Cancer Prev Res (Phila Pa). 2009. Vol. 2. P. 473483.
  • Pannellini T., Iezzi M., Liberatore M., Sabatini F., Iacobelli S., Rossi C., Alberti S., Di Ilio C., Vitaglione P., Fogliano V., Piantelli M. A dietary tomato supplement prevents prostate cancer in TRAMP mice//Cancer Prev. Res. (Phila). 2010. Vol. 3. P. 1284-1291.
  • Singh S.V., Powolny A.A., Stan S.D., Xiao D., Arlotti J.A., Warin R., Hahm E.R., Marynowski S.W., Bommareddy A., Potter D.M., Dhir R. Garlic constituent diallyl trisulfide prevents development of poorly differentiated prostate cancer and pulmonary metastasis multiplicity in TRAMP mice//Cancer Res. 2008. Vol. 68. P. 9503-9511.
  • Arunkumar A., Vijayababu M.R., Venkataraman P., Senthilkumar K., Arunakaran J. Chemoprevention of rat prostate carcinogenesis by diallyl disulfide, an organosulfur compound of garlic//Biol. Pharm. Bull. 2006. Vol. 29. P. 375-379.
  • Shukla S., MacLennan G.T., Flask C.A., Fu P., Mishra A., Resnick M.I., Gupta S. Blockade of beta-catenin signaling by plant flavonoid apigenin suppresses prostate carcinogenesis in TRAMP mice//Cancer Res. 2007. Vol. 67. P. 6925-6935.
  • Wang J., Eltoum I.E., Carpenter M., Lamartiniere C.A. Genistein mechanisms and timing of prostate cancer chemoprevention in lobund-wistar rats//Asian Pac. J. Cancer Prev. 2009. Vol. 10. P. 143-150.
  • Adhami V.M., Siddiqui I.A., Sarfaraz S., Khwaja S.I., Hafeez B.B., Ahmad N., Mukhtar H. Effective prostate cancer chemopreventive intervention with green tea polyphenols in the TRAMP model depends on the stage of the disease//Clin. Cancer Res. 2009. Vol. 15. 1947-1953.
  • Harper C.E., Cook L.M., Patel B.B., Wang J., Eltoum I.A., Arabshahi A., Shirai T., Lamartiniere C.A. Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats//Prostate. 2009. Vol. 69. P. 1668-1682.
  • Raina K., Singh R.P, Agarwal R., Agarwal C. Oral grape seed extract inhibits prostate tumor growth and progression in TRAMP mice//Cancer Res. 2007 Vol. 67. P. 5976-5982.
  • Wang L., Bonorden M.J., Li G.X., Lee H.J., Hu H., Zhang Y., Liao J.D., Cleary M.P., Lü J. Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit//Cancer Prev. Res. (Phila). 2009. Vol. 2. P. 484-495.
  • Беспалов В.Г., Муразов Я.Г., Панченко А.В., Чепик О.Ф. Изучение химиопрофилактической активности селена на комбинированной модели канцерогенеза предстательной железы//Актуальные вопросы диагностики и лечения урологических заболеваний: Материалы Х региональной научно-практической конференции урологов Западной Сибири. Барнаул, 2011. С. 139-140.
  • Lin X., Gingrich J.R., Bao W., Li J., Haroon Z.A., Demark-Wahnefried W. Effect of flaxseed supplementation on prostatic carcinoma in transgenic mice//Urology. 2002. Vol. 60. P. 919-924.
  • Shenouda N.S., Sakla M.S., Newton L.G., Besch-Williford C., Greenberg N.M., MacDonald R.S., Lubahn D.B. Phytosterol Pygeum africanum regulates prostate cancer in vitro and in vivo//Endocrine. 2007. Vol. 31. P. 72-81.
  • Wadsworth TL., Worstell TR., Greenberg N.M., Roselli C.E. Effects of dietary saw palmetto on the prostate of transgenic adenocarcinoma of the mouse prostate model (TRAMP)//Prostate. 2007. Vol. 67. P 661-673.
Еще
Статья
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp